Table 6.
Comparison of Outcomes With Previously Published Studiesa
| RFA |
TBA |
||||
|---|---|---|---|---|---|
| Study | No. | % | No. | % | RR (95% CI) |
| Treatment failure at 12 months | |||||
| Abbott et al (20), 2003 | 6/37 | 16 | 0/18 | 0 | 6.50 (0.39, 109.40) |
| Bongers et al (19), 2004 | 4/83 | 5 | 4/43 | 9 | 0.52 (0.14, 1.97) |
| Current study | 5/197 | 3 | 9/178 | 5 | 0.50 (0.17, 1.47) |
| Postablation amenorrhea | |||||
| Abbott et al (20), 2003 | 16/37 | 43 | 2/18 | 11 | 3.89 (1.00, 15.13) |
| Bongers et al (19), 2004 | 34/83 | 41 | 3/43 | 7 | 5.87 (1.91, 18.02) |
| Current study | 70/221 | 32 | 26/191 | 14 | 2.33 (1.55, 3.49) |
Abbreviations: CI, confidence interval; RFA, bipolar radiofrequency ablation; RR, risk ratio; TBA, thermal balloon ablation.
RevMan software (version 4.2.8; The Cochrane Collaboration, Oxford, United Kingdom) was used to calculate risk ratios and 95% confidence intervals using the random effects statistical method.